From the original announcement of acceptance of submission:
Acrux has submitted an ANDA application to the FDA for Lidocaine 2.5% and Prilocaine
2.5% cream, which has now been accepted for review
• Annual sales for the product were US$35m as measured by IQVIA 1
• The product is used as a topical anaesthetic
• The announcement marks Acrux’s third product accepted for review by the FDA
So... kinda? Bit of both?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.548M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 351996 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 358041 | 1 |
View Market Depth
| Last trade - 16.21pm 08/08/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable